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Background: Perioperative hair removal using clippers requires lengthy cleanup to remove loose hairs
contaminating the operative ﬁeld. We compared the amount of hair debris and associated microbio-
logic contamination produced during clipping of surgical sites using standard surgical clippers (SSC) or
clippers ﬁtted with a vacuum-assisted hair collection device (SCVAD).
Methods: Trained nurses conducted bilateral hair clipping of the chest and groin of 18 male subjects using
SSC or SCVAD. Before and during clipping, measurements of particulate matter and bacterial contami-
nation were evaluated on settling plates placed next to each subject’s chest and groin. Skin condition after
clipping and total clipping/cleanup times were compared between SSC and SCVAD.
Results: The microbial burden recovered from residual hair during cleanup in the SSC group was 3.9 log10
CFU and 4.6 log10 CFU from respective, chest, and groin areas. Use of the SCVAD resulted in a signiﬁcant
(P < .001) reduction in both residual hair and microbial contamination within the operative ﬁeld com-
pared with SSC.
Conclusions: Use of SCVAD resulted in signiﬁcant (P < .001) reduction in total time required to clip and
clean up residual hair contaminating the operative ﬁeld compared with standard practice (ie, SSC), elimi-
nating the need to physically remove dispersed hairs, which can harbor a signiﬁcant microbial burden,
from within the operative ﬁeld.
© 2016 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and
Epidemiology, Inc.
Preoperative hair removal by clipping rather than shaving was
among the Surgical Care Improvement Project’s sentinel core
measures.1 In an era of value-based purchasing, optimizing the prac-
tice of these evidence-based process measures has important
ﬁnancial implications for hospitals and other acute-care facilities.2,3
Following Association of periOperative Registered Nurses-
recommended practices, if a patient’s hair is likely to interfere with
the surgical procedure and removal is deemed warranted, the fol-
lowing practice is applied:4
• Hair removal should be performed on the day of the surgery,
in a location outside the operating or procedure room;
• Only hair interfering with the surgical procedure should be
removed; and
• Hair should be clipped with a single-use electric or battery-
operated clipper, or clipped with a reusable head that can be
disinfected between patients.
The location of perioperative hair removal has been a concern
of operating room nurses and other health care professionals because
hair can be a signiﬁcant source of microbial contamination and the
removal of residual hair is often a time-consuming practice, in-
creasing costly operating room time.5 Furthermore, on selective
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surgical services, such as cardiac, gynecology, and urology, sur-
geons prefer to clip in the operating room after the patient has been
sedated. This conforms to patient privacy concerns and the sensi-
tivity of the area being clipped.
The purpose of this study was to quantify and compare the
amount of loose hair or debris, and associated microbiologic con-
tamination, produced during the clipping of surgical sites using
standard surgical clippers (SSC) alone or surgical clippers ﬁtted with
a vacuum-assisted hair collection device (SCVAD). This study also
evaluated total clipping time, abrasion/irritation of the skin during
clipping procedures, and clinician and subject satisfaction with the
clipping and hair-removal process. The standard practice of using
surgical tape to remove residual hair following clipping was also
evaluated for its microbial bioburden because loose hair poses a risk
for microbial contamination of the surgical ﬁeld or operating room
environment.
MATERIALS AND METHODS
The protocol was reviewed and approved by the Gallatin Insti-
tutional Review Board.
Preliminary analysis
An initial pilot study was conducted to assess the feasibility of
measuring the level of dispersed microbial and residual hair con-
tamination produced during the clipping process using clippers with
or without vacuum collection technology. Following informed
consent, 3 subjects had hair clipped from the groin and lower leg
regions with or without vacuum-assisted hair collection (ClipVac
Hair Vacuum or Surgical Clipper; CareFusion Corp, San Diego, CA).
On the left or right groin sites, a sterile surgical marker was used
to demarcate a 12-inch × 8-inch bilateral area with a similar amount
of hair. Tryptic soy agar (TSA) settling plates were placed adjacent
to the test site before clipping. The TSA plates were placed in a 2
plate × 4 plate formation (ie, 8 plates) such that the open plates were
positioned beneath the clipping site at 3.25 inches, 6.50 inches, 9.75
inches, and 13.00 inches perpendicular to the test site. The plates
were exposed for 3 minutes (negative control), removed, and in-
cubated at 30°C for 48 hours. A second set of plates were placed
in the exact same position as the ﬁrst set. The skin surface was care-
fully clipped until it was visually apparent that all hair had been
removed from the test sites using either SSC or SCVAD. The plates
were removed, incubated at 30°C for 48 hours, and microbial colo-
nies from both negative control and experimental runs enumerated.
A visual inspection of the groin skin surfaces adjacent to the clip-
ping site revealed no residual hair particles following removal with
the SCVAD.
On the skin of the lower leg, a surgical marker was used to de-
marcate the front plane of the lower leg with areas of skin that
appeared bilaterally similar in terms of the amount of hair. A
preweighed piece of paper was place beneath each leg. The hair was
carefully clipped until it was visually apparent that hair was en-
tirely removed from the test site by either the SSC or SCVAD. The
preweighed pieces of paper were removed from beneath the vo-
lunteer’s leg and reweighed. A visual inspection of the lower leg skin
surfaces adjacent to the clipping site revealed no residual hair par-
ticles following removal with SCVAD.
Simulated surgical clipping study
Following informed consent and before randomization, the skin
of the study subjects were examined to assess that it was free from
clinically evident diseases, injuries, or any other disorders that could
compromised the study.
Inclusion/exclusion criteria
Subjects were included in this study if they met the following
requirements:
• Male, aged at least 18 years, including any ethnic background,
• Moderate to heavy (≥ 3 on Ferriman-Gallwey scale for hirsut-
ism) hair on chest and groin,6
• Available to take a shower or bathe approximately 24 hours
before testing, and
• In good general health.
Subjects were excluded if they had any of the following criteria:
• Presence of tattoos, insuﬃcient hair, scars, erythema, sunburn,
skin diseases, moles, cuts, lesions, skin tags, protruding veins,
or other disorders on the skin of the chest or groin that might
have interfered with consistent use of the test materials across
a test site or with the evaluation of responses to test material
use;
• Known allergy or sensitivity to sunscreens, deodorants, laundry
detergents, fragrances, latex (rubber), metals, adhesives, or ink;
• Exposure of test sites to strong detergents, solvents, or other
irritants within a 7-day pretest conditioning period or on the
single test day;
• Exposure of test sites to antimicrobial agents, medicated soaps,
medicated shampoos, or medicated lotions, use of biocide-
treated pools or hot tubs, use of tanning beds, or sunbathing
during the 7-day pretest conditioning period or on the single
test day;
• Use of systemic or topical antibiotic medications, steroid medi-
cations, or any other products known to affect the normal
microbial ﬂora of the skin during the 7-day pretest condition-
ing period or the single test day;
• Removal of hair from any portion of the test sites within the
prior 30 days; and
• Any currently active skin disease or inﬂammatory skin condi-
tion, such as contact dermatitis, eczema, or psoriasis, anywhere
on the body or use of any medications that, in the opinion of
the principal investigator or medical consultants, should pre-
clude participation.
A total of 24 men consented to participate in the study; 5 sub-
jects were excluded during preliminary examination, 19 received
study materials, and 18 subjects completed the study without any
protocol violations.
Pretesting period
Seven days before the study, subjects were instructed to avoid
use of medicated soaps, lotions, deodorants, and shampoos, as well
as skin contact with solvents, detergents, acids and bases, or any
other products known to affect the normal microbial populations
of the skin. Subjects were provided with a personal hygiene kit con-
taining nonmedicated soap, shampoo, lotion, and rubber gloves to
be worn when in contact with antimicrobial agents, solvents, de-
tergents, acids, or bases that could not be avoided. Subjects were
instructed to exclusively use the contents of the kit during their
participation in the study. The study subjects were instructed not
to shave or clip the test sites during the 7 days before their as-
signed test day. Subjects were instructed to avoid swimming or
bathing in biocide-treated pools or hot tubs. Subjects were also told
that they must shower or bathe approximately 24 hours before
testing.
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Study period
A computer-generated randomization method was used to ran-
domly assign which matched sites (chest and groin) were to be
clipped using SCVAD compared with SSC. Table 1 documents the
test procedure assignments for both the chest and groin test sites.
Test sites were visually inspected by a trained technician and nurse.
The height and weight of each subject was used to determine body
mass index. The matched right or left chest sites tested included
the anterior aspect of the chest between the umbilicus and the clav-
icle on each side of the midline. The matched inguinal test sites
included the medial aspect of the right or left thigh. A sterile sur-
gical marker was used on the inguinal test sites, standardizing a 12-
inch × 8-inch templated area for clipping.
Baseline measurements of potential microbial contamination
were evaluated using settling TSA Petri dishes placed next to each
subject’s chest (4 plates) and groin (6 plates) with the tops removed
and exposed for 10 ± 1 minutes. Simultaneously, baseline measure-
ments of airborne particulate matter were evaluated via an airborne
particle counter instrument (DustTrak DRX Aerosol Monitor 8534;
TSI Incorporated, Shoreview, MN) that was hung from a portable
intravenous line pole placed as close to the site of clipping as
possible. An assessment of skin condition was made before any
clipping of the chest using a mexameter (Courage & Khazaka
Electronic GmbH, Cologne, Germany) to measure skin erythema
and a tewameter (Courage & Khazaka Electronic) to measure
transepidermal water loss (TEWL), together with visual evalua-
tion of erythema and dryness. No assessment of skin condition of
the groin was conducted. The location of each measurement was
marked using a sterile surgical marker to ensure that later mea-
surements were taken from the same location.
Following baseline measurements, 3 trained nurses clipped sub-
jects bilaterally using the randomly assigned clippers (SSC or SCVAD),
beginning with the chest and then groin. New TSA settling plates
were placed next to the test sites in the same earlier conﬁguration
to capture airborne hair particles during the clipping process. The
microbial contamination was quantiﬁed for comparison to base-
line. These plates were left open for the duration of clipping.
Following clipping, the TSA plates were gently shaken to distrib-
ute any loose hair across the surface of the plate. Measurement of
airborne particulate matter was evaluated during clipping using the
airborne-particle counter instrument. Airborne particulate sam-
pling began at approximately the same time as opening of the
settling plates and ended once clipping was completed.
The length of time required for each clipping procedure, using
either the SSC or SCVAD devices, was measured. Airborne partic-
ulate matter was sampled immediately after clipping using the
airborne particle counter for a period of 3 minutes. In addition, skin
surface readings using the mexameter and tewameter and visual
evaluation of erythema or dryness were conducted immediately after
each chest clipping. Erythema measurements and TEWL were as-
sessed solely on chest sites due to the diﬃculty of conducting these
studies in the groin. Any excess clipped hair contaminating the op-
erative ﬁeld was removed by a nurse using a 12-inch section of
surgical tape while wearing sterile gloves. Microbial bioburden eval-
uation was performed on the surgical tape to determine the level
of microbial contamination present. Five 12-inch portions of unused
surgical tape were each placed aseptically into separate sterile stom-
acher bags for use in determining the background bioburden present
on tape before contact with each subjects’ skin. Each used portion
of surgical tape was also placed into a separate sterile stomacher
bag following use. Twenty milliliters stripping suspending ﬂuid was
poured into each bag and the bag massaged in a uniform manner
for 60 seconds using a Seward 400 Stomacher machine (Cole-
Parmer, Vernon Hills, IL). Following massage, a 5-mL aliquot was
removed from each bag and placed into a sterile test tube and se-
rially diluted for quantitative plate counts. Duplicate spread plates
(using TSA) were prepared from appropriate dilutions using But-
terﬁeld’s Phosphate Buffer solution. Colony counts were determined
following incubation for 72 hours at 30°C.
The nurses who performed the clipping and study subjects were
queried following hair removal regarding their opinions on eﬃca-
cy and comfort associated with use of the SSC or SCVAD.
Analytical and statistical analysis
The estimated Log10 number of viable microorganisms recov-
ered from surgical tape bioburden samples from each sample site
was designated the R value. To convert the recorded colony counts
from each sample into the Log10 colony forming units, the follow-
ing formula was employed:
R = × ×[ ]−Log Ci D10 20 10
Where 20 = the amount (in milliliters) of stripping suspending
ﬂuid used in sampling, Ci = the arithmetic average colony count of
the 2 plate counts from each sample at a particular dilution level,
and D = the dilution factor. An analysis of variance (ANOVA) was con-
ducted for each test site (chest or groin) using the following factors,
as applicable. This ANOVA was of the form:
ˆy Blocks A e= + +
Where ˆy = 1 of 7 factors:
1. Combined duration of clipping and hair collection—groin,
2. Combined duration of clipping and hair collection—chest,
Table 1
Test assignments for subjects undergoing clipping of chest and groin
Site Performance differentiator evaluated Standard surgical clipper
Surgical clippers with vacuum-assisted hair
collection device
Chest
and
groin
Time to clip and removal and hair particulate
collected
Hair clipped with standard surgical clipper and removed
with tape
Particulate matter on tape used for hair cleanup weighed
Hair clipped with surgical clippers with
vacuum-assisted hair collection device
Hair particulate dispersion and associated
microbial contamination
Settling plates collected before and during clipping
Airborne particulate matter measured with airborne particle counter instrument before and during clipping
Irritation/microabrasion of surgical site*
Subject–clinician satisfaction
Mexameter (erythema) and tewameter (transepidermal water loss) readings and visual evaluation of
erythema/dryness before clipping, following clipping, and following postclipping hair removal
Subject–clinician questionnaire
Bioburden evaluation on surgical tape Tape was sampled following use for microbial
contamination
Not applicable
*Chest-speciﬁc.
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3. Amount of hair (collected via settling plates)—groin,
4. Amount of hair (collected via settling plates)—chest,
5. Microbial contamination from clipping—groin,
6. Microbial contamination from clipping—chest, and
7. Erythema or TEWL (chest),
A = test agent; that is, SSC or SCAD, and e = error (factor).
RESULTS
In the preliminary pilot analysis, the mean dispersed microbial
recovery (Log10 colony-forming units) associated with inguinal hair
removal from test subjects using the SSC or SCVAD is reported in
Table 2. In addition, themeanweight of recovered hair from beneath
the test site on the volunteer’s lower leg clipped with SSC was 0.212
g, whereas the mean weight of hair recovered from beneath the test
site clipped with SCVAD was 0.003 g. These preliminary ﬁndings
suggest that compared with SSC, the SCVAD was highly effective
in reducing the dispersion of contaminated hair ﬁbers within the
areas adjacent to the skin-prepping site.
The ﬁndings from the operating room-simulated study docu-
ment that the use of SSC required a signiﬁcantly (ANOVA, P < .001)
longer time for clipping and cleanup/removal (combined dura-
tion) of hair from chest test sites comparedwith use of SCVAD.When
SSC were used, it took more than 5.3 minutes for clipping and
cleanup/removal of hair from chest sites, whereas use of SCVAD re-
quired approximately 3.2 minutes. In the groin, use of a SSC required
a signiﬁcantly (ANOVA, P < .001) longer time for clipping and hair
cleanup/removal (combined duration) compared with use of the
SCVAD. It took approximately 4.2 minutes (maximum, 8.5 minutes)
for clipping and cleanup/removal of hair from groin test sites when
SSC were used, whereas use of the SCVAD required approximately
2.7 minutes (maximum, 4.9 minutes).
The use of SSC without vacuum-assisted hair removal (and sub-
sequent hair removal with surgical tape) resulted in signiﬁcantly
(ANOVA, P < .001) more loose hairs (on a Log10 scale) dispersed from
chest test sites than following use of the SCVAD. The use of SSC (and
subsequent hair removal with surgical tape) resulted in signiﬁ-
cantly (ANOVA, P < .001)more loose hairs (on a Log10 scale) dispersed
from groin test sites compared with SCVAD. The mean particulate
hair contamination (and 95% conﬁdence intervals) from chest and
groin test sites following use of SSC or SCVAD are documented in
Figure 1.
The use of the SSC (and subsequent hair removal with surgical
tape) resulted in signiﬁcantly (ANOVA, P < .001) moremicrobial con-
tamination from chest test sites than following use of the SCVAD.
The use of the SSC without the vacuum-assisted hair removal (and
subsequent hair removal with surgical tape) produced signiﬁ-
cantly (ANOVA, P < .003) more microbial contamination from groin
Table 2
Pilot summary of mean Log10 (colony forming units) microbial recovery (difference) between pre- and postclipping agar plates from inguinal sites clipped with standard
surgical clipper (SSC) versus surgical clipper ﬁtted with vacuum-assisted device (SCVAD)
Samples
Sample size
SSC/SCVAD
Mean
SSC/SCVAD
Standard deviation
SSC/SCVAD
Minimum
SSC/SCVAD
Maximum
SSC/SCVAD
Agar plates 3.25 in from inguinal site 6/6 1.87/0.23 0.69/0.36 1.05/0.00 2.68/0.70
Agar plates 6.50 in from inguinal site 6/6 0.55/0.13 0.46/0.37 −0.18/−0.48 1.08/0.48
Agar plates 9.75 in from inguinal site 6/6 0.09/0.02 0.27/0.34 −0.30/−0.48 0.48/0.60
Agar plates 13.00 in from inguinal site 6/6 0.18/0.03 0.27/0.25 0.00/−0.30 0.70/0.48
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Fig 1. Volume (Log10) of hair (and 95% conﬁdence intervals) collected via settling plates using standard surgical clipper (SSC) (control) or surgical clippers with vacuum-
assisted hair collection device (SCVAD) on chest and groin (P < .001).
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test sites than following use of the SCVAD. The meanmicrobial con-
tamination (and 95% conﬁdence intervals) from comparative chest
sites and groin sites following use of SSC or SCVAD are docu-
mented in Figure 2. The mean microbial contamination recovered
from surgical tape following clipping with SSC in the chest and groin
was in excess of 3.5 Log10 cfu, with a maximal microbial recovery
of 5.4 and 6.2 Log10 cfu from chest and groin sites, respectively.
The use of the SSC or SCVAD produced equivalent (ANOVA,
P = .124) skin changes from baseline erythema measurements for
chest test sites following tape removal of residual hair clippings. The
use of the SCC (and subsequent hair removal with surgical tape) pro-
duced a signiﬁcantly (P < .001) higher measured change in TEWL
at chest test sites compared with use of the SCVAD; that is, 1.12 g/h/
m2 and −0.55 g/h/m2, respectively. Following study completion, study
nurses responded that the beneﬁts of using the SCVAD included an
increase in speed of clipping and a signiﬁcant increase in cleanli-
ness following the clipping process, whereas study subjects indicated
that they experienced little to no discomfort during the clipping
process.
DISCUSSION AND PRACTICAL IMPLICATIONS
Despite efforts to institute national initiatives and guidelines to
reduce the risk of health care-associated infections, selective in-
fections such as postoperative wound infections persist as a source
of signiﬁcant patient morbidity and mortality.7 Preparation for
surgery has historically involved the routine removal of body hair
at and around the operative site. The rationale for hair removal has
been centered around the concern that body hair may interfere with
visualization of the surgical wound, closure of the surgical inci-
sion, diminished adherence of incised drapes to the skin, or possibly
a reduction in the effectiveness of skin antisepsis at the incision site
due to bacterial contamination. Evidence-based practice suggests
that hair removal using an exposed blade or razor may increase the
risk of wound contamination due to the presence of microscopic
nicks or scratches that occur during the shaving process.8-12 These
microscopic injuries are rapidly colonized, increasing the microbi-
al skin burden leading to an increased risk of wound infection.11 The
1999 Centers for Disease Control and Prevention Guidelines for the
Prevention of Surgical Site Infections indicate that, “If hair is to be
removed, remove immediately before the operation, preferably with
electric clippers” (Category 1A evidence-based).13
Both the Centers for Disease Control and Prevention and Asso-
ciation of periOperative Registered Nurses recommendations state
that hair removal should be conducted outside the operating room.
Although there has never been an evidence-based analysis of
whether clipping (hair removal) within an operating room repre-
sents a speciﬁc health care-associated infection risk factor, it often
represents a focus of discussion among members of the operative
team. Time and space constraints along with concerns for patient
privacy often dictate that hair removal should occur within the op-
erating room and that the entire process from clipping to cleanup
can occupy several minutes of dedicated operating room time. In
addition, the clipping process with a battery-operated clipper, de-
pending upon the amount of body hair, can disperse hair particles
over a wide area, depositing hair several inches from the clipped
surgical site (Table 2). The results of this study suggest that the at-
tachment of an SCVAD to the head of the surgical clipper is effective
in removing hair at the point of clipping. The hair is drawn up into
the hood of the SCVAD and collected in an end-stage ﬁlter. The ﬁlter
cassette is capable of collecting a large volume of hair, preventing
hair particle dispersion within the surgical ﬁeld or operating room
environment (Fig 3). The vacuum is achieved by a lithium-ion
powered pumpweighing approximately 1.6 lb. The system is highly
portable and can be moved easily from room to room as needed.
The results of this study document that clipped hair particles are
associated with notable microbial contamination. The use of a
battery-operated surgical clipper with innovative vacuum-assisted
technology for collection of surface hair before surgery is effective
(P < .001) in the rapid removal and collection of hair particles that
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Fig 2. Mean microbial contamination following hair removal using standard surgical clippers (SSC) (control) or surgical clippers with vacuum-assisted hair collection device
(SCVAD) on chest and groin (P < .001).
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may pose a risk for contamination of the operative site. The inves-
tigation documented that postclipping cleanup of the patient’s skin
and surrounding adjacent surface areas can be eliminated by using
a clipper with vacuum-assisted technology, sequestering clipped hair
particles within a closed container, resulting in substantial time
savings before perioperative skin antisepsis and draping. The in-
vestigation also demonstrated a mean increase in TEWL following
hair clipping with SSC and cleanup of residual hair particles using
surgical tape. An increase in TWEL suggests that following repeat
applications of surgical tape to skin test sites, structural changes
occurred that affected themoisture balance in the outermost portion
of the stratum corneum. TEWL is by convention used as a marker
for skin barrier function that in the present study was altered during
postclipping cleanup. The removal of residual hair with adhesive
tape often required multiple passes to ensure complete removal of
clipped hair from the surgical ﬁeld before skin antisepsis. When the
tape was sampled for microbial burden, a mean colony count of 3.9
Log10 CFU and 4.6 Log10 CFU was recovered from the chest and groin,
respectively, suggesting that clipped hair can be a signiﬁcant source
of bacterial contamination within the surgical ﬁeld.
Previous studies in our laboratory have documented that a wide
range of microbial populations, including Staphylococcus aureus,
Staphylococcus epidermidis, and selective gram-negative bacteria are
present within 1-2 m of the incision site, posing a potential risk of
infection, particularly when procedures involve insertion of a bio-
medical device or prosthesis.14 The ﬁndings of the current study
document that using a battery-operated surgical clipper ﬁtted with
vacuum-assisted hair collection technology was effective in the com-
plete removal of clipped hair particles from the operative ﬁeld.
Finally, in addition to eliminating the time required to clean up re-
sidual hair particles, the vacuum-assisted collection system was
effective at reducing the potential microbial burden associated with
clipped loose hair as a potential source of operative ﬁeld contam-
ination. Further research is warranted to evaluate the potential
beneﬁts of this innovative perioperative hair removal/collection
technology.
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Fig 3. Picture of opened collection ﬁlter cassette, demonstrating large volume of
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